Wedell-Wedellsborg Johan

CIK 00017531851 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001753185

Recent Transactions

50 trades

Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−11,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−14,545→ 0 total
Disposition from Tender
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16$8.60/sh−4,559,233→ 0 total
Disposition from Tender
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16$8.60/sh−5,825→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−32,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−13,950→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−16,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16−25,080→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−33,450→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−16,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−36,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−11,000→ 0 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-06-30+33,450→ 33,450 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2025-06-30+25,080→ 30,905 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2024-06-11+3,495→ 5,825 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-06-11+14,545→ 14,545 total
Purchase
Y-mAbs Therapeutics, Inc.
Common Stock
2023-12-11$7.01/sh+102,863→ 4,552,778 total
Purchase
Y-mAbs Therapeutics, Inc.
Common Stock
2023-12-11$6.85/sh+6,455→ 4,559,233 total
Purchase
Y-mAbs Therapeutics, Inc.
Common Stock
2023-12-08$6.99/sh+18,503→ 4,449,915 total
Purchase
Y-mAbs Therapeutics, Inc.
Common Stock
2023-12-07$6.50/sh+6,183→ 4,431,412 total
Purchase
Y-mAbs Therapeutics, Inc.
Common Stock
2023-11-29$5.97/sh+51,837→ 4,425,229 total
Purchase
Y-mAbs Therapeutics, Inc.
Common Stock
2023-11-28$5.81/sh+30,671→ 4,373,392 total
Purchase
Y-mAbs Therapeutics, Inc.
Common Stock
2023-11-27$5.49/sh+62,516→ 4,342,721 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-06-08+13,950→ 13,950 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2023-06-08+2,330→ 2,330 total
Purchase
Y-mAbs Therapeutics, Inc.
Common Stock
2023-05-15$9.65/sh+101,740→ 4,280,205 total
Award
Y-mAbs Therapeutics, Inc.
Non-Employee Stock Option (right to buy)
2022-07-15+16,000→ 16,000 total
Award
Y-mAbs Therapeutics, Inc.
Non-Employee Stock Option (right to buy)
2021-06-10+16,000→ 16,000 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-06-10$36.15/sh−11,229→ 4,178,465 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-06-09$36.19/sh−116,700→ 4,189,694 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-06-08$35.28/sh−33,300→ 4,306,394 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-06-07$34.15/sh−72,400→ 4,339,694 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-06-04$34.03/sh−3,841→ 4,412,094 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-06-03$33.19/sh−30,666→ 4,415,935 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-06-01$35.57/sh−6,864→ 4,446,601 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-05-28$36.34/sh−25,000→ 4,453,465 total
Other
Y-mAbs Therapeutics, Inc.
Common Stock
2021-03-10−1,029,927→ 4,478,465 total
Award
Y-mAbs Therapeutics, Inc.
Non-Employee Stock Option (right to buy)
2020-06-23+16,000→ 16,000 total
Other
Y-mAbs Therapeutics, Inc.
Common Stock
2019-12-30+498,392→ 5,508,392 total
Other
Y-mAbs Therapeutics, Inc.
Common Stock
2019-12-30−498,392→ 0 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2019-09-06$27.00/sh−5,791→ 498,392 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2019-09-05$27.00/sh−11,452→ 504,183 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2019-08-30$27.00/sh−100→ 515,635 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2019-08-29$26.58/sh−89,066→ 515,735 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2019-08-28$27.02/sh−29,552→ 604,801 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2019-08-27$27.18/sh−19,805→ 634,353 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2019-08-22$27.75/sh−990→ 654,158 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2019-08-21$27.83/sh−60,116→ 655,148 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2019-08-21$27.83/sh−60,116→ 664,147 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2019-08-20$27.42/sh−108,128→ 715,264 total

Companies

Y-mAbs Therapeutics, Inc.
Director, 10% Owner

Recent Filings

Address

C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, SUITE 3350

NEW YORK, NY, 10169

View on SEC.gov